
Keywords: BM; bone marrow; CCL; chemokine (C-C motif) ligand; c-MYC; avian myelocytomatosis virus oncogene cellular homolog; CX3CR1; CX3C chemokine receptor 1; GSK3-β; glycogen synthase kinase 3 beta; IC50; half-maximal inhibitory concentration; LIF; leukemia inhi